Geneva: A WHO The official said that the agency’s assessment of Made-in-India covaxin It is in an advanced stage and a decision on emergency authorization for Bharat Biotech’s vaccine is likely by mid-September. Covaxin still has to be authorized by Western authorities.
a top vaccine official in World Health Organization says the agency is expected to decide next month on an emergency authorization for an Indian-made Covid-19 vaccine made by Bharat Biotech, a shot that has not yet been authorized by any Western regulatory authority.
Dr. Mariangela Simao, WHO’s Assistant Director General for Vaccines, says, a The health agency’s evaluation of the Bharat Biotech vaccine was “quite advanced” and officials expected a decision by mid-September.
Simao says the WHO is already considering other versions of vaccines licensed by the agency, including one made by Sinopharm. They hope to start evaluating vaccines made by Sanofi Pasteur and novavax in September. “There are many, many vaccines in the final stages of the pipeline,” Simao says.
Last week, US manufacturers of Novavax said they would prioritize getting authorization from developing countries and the WHO before getting the green light in the US. The European Union.
a top vaccine official in World Health Organization says the agency is expected to decide next month on an emergency authorization for an Indian-made Covid-19 vaccine made by Bharat Biotech, a shot that has not yet been authorized by any Western regulatory authority.
Dr. Mariangela Simao, WHO’s Assistant Director General for Vaccines, says, a The health agency’s evaluation of the Bharat Biotech vaccine was “quite advanced” and officials expected a decision by mid-September.
Simao says the WHO is already considering other versions of vaccines licensed by the agency, including one made by Sinopharm. They hope to start evaluating vaccines made by Sanofi Pasteur and novavax in September. “There are many, many vaccines in the final stages of the pipeline,” Simao says.
Last week, US manufacturers of Novavax said they would prioritize getting authorization from developing countries and the WHO before getting the green light in the US. The European Union.
.